Wellington Partners
Finance · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
96 Kensington High Street, London, Great...Phone Number
+49 892199410Website
www.wellington-partners.comRevenue
$5.8 MillionIndustry
About Wellington Partners
Is Wellington Partners your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Wellington Partners had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Wellington Partners
Check out if Wellington Partners is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Wellington Partners has new funding data
Check if Wellington Partners has recently received funding, and reach out quickly before it becomes old news!
Wellington Partners, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Wellington Partners recently announced quarterly report
Product Launch: Get notified when Wellington Partners launches new products
Recommended Actions
Find VP level buyers at Wellington Partners
Find more new buyers
Company Profile Activity
Activity Insights
Wellington Partners is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Wellington Partners is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Wellington Partners.
Wellington Partners Tech Stack
A closer look at the technologies used by Wellington Partners
Most Recent Scoops
Wellington Partners News & Media
UroMems Raises $47M in Series C Financing
UroMems, a Grenoble, France- and Minneapolis, MN-based-based company developing implantable mechatronics technology, raised $47M in Series C funding. The round was led by Crédit Mutuel Innovation and joined by the European Innovation Council as well as existing investors Wellington Partners, Bpifrance, Supernova Invest, Hil-Invent, b-to-v Partners and Financière Arbevel. The company intends to use the […] The post UroMems Raises $47M in Series C Financing appeared first on FinSMEs.MinervaX Raises EUR 54M in Upsized Financing
MinervaX, a Copenhagen, Denmark-based biotechnology company, raised EUR54M in upsized financing. The round was led by EQT Life Sciences and OrbiMed, with participation from existing investors Novo Holdings, Pureos Ventures, Sanofi Ventures, Trill Impact Ventures, Adjuvant Capital, Wellington Partners, Industrifonden, Sunstone LifeScience Ventures, and LF Invest. The company intends to use the funds to support its efforts to […] The post MinervaX Raises EUR 54M in Upsized Financing appeared firstNyra Pitch Deck: Digital Neurotherapy Startup Secures $4.9 Million - Business Insider
Nyra, a digital therapy startup, aims to support patients with neurological conditions like dementia or long COVID.Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases
DRESDEN, Germany--(BUSINESS WIRE)--Seamless Therapeutics today announced a $12.5 million (€11.8M) seed financing round which will accelerate further development of its designer recombinases, a novel gene editing platform to transform the treatment of severe diseases. The company’s pioneering recombinase platform is able to program a widely used and established molecular biology tool to unlock the full potential of gene editing enabling the targeting of any site within the genome. The seed round
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Wellington Partners
Wellington Partners is a leading European venture capital firm that invests in early- and growth-stage life science companies across various sectors, including therapeutics, medical devices, diagnostics, digital health, and industrial biotechnology. Since its inception in 1998, the firm has supported outstanding entrepreneurs in transforming their... Read More